SOD3 regulates FLT1 to affect bone metabolism by promoting osteogenesis and inhibiting adipogenesis through PI3K/AKT

Ke Xu1, Wenchao Fei1, Wenxue Gao2

  • 1Department of Orthopedics, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China; Shanghai Clinical Research Center for Aging and Medicine, Shanghai, China; Center of Community-Based Health Research, Fudan University, Shanghai, China.

PubMed

Insights

Superoxide Dismutase 3 (SOD3) promotes bone formation and inhibits fat accumulation in bone marrow, offering new therapeutic targets for osteoporosis treatment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Bone Metabolism

Background:

  • Osteoporosis significantly impacts elderly health and longevity, necessitating research into its mechanisms for drug development.
  • Bone marrow mesenchymal stem cells (BMSCs) have potential for altering bone mass by directing their differentiation.
  • Superoxide Dismutase 3 (SOD3), an extracellular enzyme, plays roles in various organs, but its specific function in bone metabolism remains largely unknown.

Purpose of the Study:

  • To investigate the role of Superoxide Dismutase 3 (SOD3) in bone metabolism.
  • To elucidate the mechanism by which SOD3 influences osteogenesis and adipogenesis.
  • To identify molecular pathways and interactions involved in SOD3-mediated bone regulation.

Main Methods:

  • Analysis of clinical serum samples using ELISA and single-cell sequencing.
  • In vitro experiments on BMSCs to assess osteogenesis and adipogenesis.
  • In vivo studies using SOD3 knockout mice, including bone mineral density measurements, HE staining, and IHC staining.
  • Transcriptome sequencing to identify downstream targets of SOD3.
  • Western blot (WB) analysis to confirm molecular pathway involvement.

Main Results:

  • SOD3 expression positively correlates with bone mass and is primarily found in osteoblasts and adipocytes within BMSCs.
  • SOD3 promotes osteogenesis and inhibits adipogenesis in vitro.
  • SOD3 knockout mice exhibit reduced bone mineral density, increased bone marrow fat accumulation, and weakened osteogenesis.
  • SOD3 influences FLT1 expression, and FLT1 also promotes osteogenesis and inhibits adipogenesis.
  • SOD3 regulates FLT1 via the PI3K/AKT and MAPK signaling pathways.

Conclusions:

  • SOD3 plays a critical role in maintaining bone metabolism by promoting osteogenesis and inhibiting adipogenesis.
  • SOD3 exerts its effects on bone through the regulation of FLT1 expression and activation of the PI3K/AKT and MAPK pathways.
  • Targeting SOD3 and its downstream pathways presents a promising therapeutic strategy for managing osteoporosis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K